{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:00:50Z","timestamp":1788242450952,"version":"build-2803163510"},"reference-count":119,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.urolonc.2004.04.029","type":"journal-article","created":{"date-parts":[[2004,7,21]],"date-time":"2004-07-21T14:22:43Z","timestamp":1090419763000},"page":"225-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["The role of retroperitoneal lymph node dissection in the management of testicular cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Andrew J","family":"Stephenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Sheinfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2004.04.029_BIB1","first-page":"3275","article-title":"Testicular cancer as a model for a curable neoplasm","volume":"41","author":"Einhorn","year":"1981","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB2","first-page":"5","article-title":"Cancer statistics, 2003","volume":"53","author":"Jemal","year":"2003","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0090-4295(94)80002-2","article-title":"Nonseminomatous germ cell tumors of the testis","volume":"44","author":"Sheinfeld","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-5347(17)52904-3","article-title":"Distribution of nodal metastases in nonseminomatous testis cancer","volume":"128","author":"Donohue","year":"1982","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1063-5777(05)70124-9","article-title":"Lymphatic drainage of the testis","volume":"7","author":"Weinstein","year":"1999","journal-title":"Atlas Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0094-0143(21)00352-9","article-title":"Evolution of the management of stage I nonseminomatous germ-cell tumors of the testis","volume":"18","author":"Sogani","year":"1991","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB7","first-page":"55","article-title":"Surgical treatment of adult germinal testis tumors","volume":"6","author":"Whitmore","year":"1979","journal-title":"Semin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2214\/ajr.169.2.9242768","article-title":"CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer","volume":"169","author":"Hilton","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0090-4295(94)80056-1","article-title":"Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumors","volume":"44","author":"Fernandez","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0022-5347(17)36046-9","article-title":"Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989)","volume":"149","author":"Donohue","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB11","series-title":"Impact of trends in patient selection for retroperitoneal lymph node dissection on retroperitoneal pathology and clinical outcome for patients with nonseminomatous germ cell tumor","author":"Stephenson","year":"2004"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.2003.07.169","article-title":"Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors","volume":"21","author":"Albers","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB13","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<1002::AID-CNCR27>3.0.CO;2-A","article-title":"Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis","volume":"83","author":"Heidenreich","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.1990.8.3.509","article-title":"Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis","volume":"8","author":"Klepp","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB15","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0022-5347(05)67528-3","article-title":"Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection","volume":"163","author":"Hermans","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB16","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0022-5347(17)38567-1","article-title":"Staging relationships and outcome in early stage testicular cancer","volume":"145","author":"McLeod","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB17","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0022-5347(17)39681-7","article-title":"Clinical stage 1 testicular cancer","volume":"144","author":"Richie","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0022-5347(01)63753-4","article-title":"Clinical stage I testis cancer","volume":"159","author":"Sogani","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB19","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0022-5347(17)43652-4","article-title":"Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis","volume":"138","author":"Pizzocaro","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB20","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1200\/JCO.1991.9.9.1543","article-title":"Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. Danish Testicular Cancer Study Group","volume":"9","author":"Rorth","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1200\/JCO.1992.10.4.564","article-title":"Surveillance after orchidectomy for patients with clinical stage I nonseminomatous testis tumors","volume":"10","author":"Sturgeon","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB22","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.1995.13.5.1188","article-title":"Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up","volume":"13","author":"Gels","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB23","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/1097-0142(19840315)53:6<1363::AID-CNCR2820530624>3.0.CO;2-I","article-title":"Retroperitoneal lymphadenectomy and aggressive chemotherapy in nonbulky clinical Stage II nonseminomatous germinal testis tumors","volume":"53","author":"Pizzocaro","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB24","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/0959-8049(95)00330-L","article-title":"Clinical stage B non-seminomatous germ cell testis cancer","volume":"31A","author":"Donohue","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB25","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1200\/JCO.2003.03.184","article-title":"Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses","volume":"21","author":"Oldenburg","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB26","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1200\/JCO.1990.8.10.1683","article-title":"Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors","volume":"8","author":"Toner","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB27","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1200\/JCO.1995.13.5.1170","article-title":"Late relapse of testicular cancer","volume":"13","author":"Baniel","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1200\/JCO.2003.03.019","article-title":"Update on late relapse of germ cell tumor","volume":"21","author":"George","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB29","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/1097-0142(19820801)50:3<548::AID-CNCR2820500327>3.0.CO;2-2","article-title":"Autopsy findings in 154 patients with germ cell tumors of the testis","volume":"50","author":"Bredael","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB30","first-page":"12","article-title":"Late recurrence of testicular cancer","volume":"6","author":"Sheinfeld","year":"2001","journal-title":"AUA News"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1245\/ASO.2003.01.011","article-title":"Risks of the uncontrolled retroperitoneum","volume":"10","author":"Sheinfeld","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5347(17)39348-5","article-title":"Prognostic assessment in nonseminomatous testicular cancer","volume":"144","author":"Hesketh","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB33","series-title":"Cancer","first-page":"1491","article-title":"Cancer of the testis","author":"Bosl","year":"2001"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB34","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(87)90889-0","article-title":"Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone","volume":"2","author":"Freedman","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB35","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1200\/JCO.1992.10.11.1762","article-title":"Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party","volume":"10","author":"Read","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1200\/JCO.1998.16.1.261","article-title":"Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease","volume":"16","author":"Leibovitch","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1200\/JCO.1986.4.1.35","article-title":"Orchiectomy alone in clinical stage I nonseminomatous testis cancer","volume":"4","author":"Pizzocaro","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB38","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(82)90710-3","article-title":"Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours","volume":"2","author":"Peckham","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/01.ju.0000101513.64777.f2","article-title":"A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only","volume":"171","author":"Nicolai","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB40","first-page":"179A","article-title":"Is retroperitoneal lymph node dissection (RPLND) alone optimal or sufficient therapy for clinical stage I nonseminomatous germ cell testicular tumors (NSGCTT) at high risk for relapse?","volume":"158","author":"Swanson","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB41","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0022-5347(17)50575-3","article-title":"No adjuvant chemotherapy in selected patients with pathologic stage II nonseminomatous germ cell tumors of the testis","volume":"131","author":"Pizzocaro","year":"1984","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB42","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1200\/JCO.2001.19.7.2020","article-title":"Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer","volume":"19","author":"Rabbani","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB43","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJM198712033172303","article-title":"Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer","volume":"317","author":"Williams","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB44","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1200\/JCO.1991.9.8.1393","article-title":"Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer?","volume":"9","author":"Richie","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1200\/JCO.1983.1.3.171","article-title":"Stage II nonseminomatous testicular cancer","volume":"1","author":"Vogelzang","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0022-5347(17)45705-3","article-title":"Prognostic factors in nonseminomatous testicular cancer","volume":"135","author":"Javadpour","year":"1986","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB47","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1200\/JCO.2004.07.178","article-title":"Relapse-free and overall survival in patients with pathologic stage ii nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy","volume":"22","author":"Kondagunta","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00005392-199501000-00030","article-title":"The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer","volume":"153","author":"Donohue","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB49","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0022-5347(01)66867-8","article-title":"Late relapse of clinical stage I testicular cancer","volume":"154","author":"Baniel","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB50","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.urology.2003.08.045","article-title":"Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis","volume":"63","author":"Amato","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB51","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0022-5347(01)61615-X","article-title":"Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors","volume":"161","author":"Bohlen","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB52","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.1996.14.4.1106","article-title":"Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis","volume":"14","author":"Cullen","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB53","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1996.14.2.441","article-title":"Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer","volume":"14","author":"Pont","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB54","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0022-5347(17)36937-9","article-title":"Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk stage 1 malignant teratoma on overall relapse rate of stage 1 cancer patients","volume":"148","author":"Oliver","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB55","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/1097-0142(19821015)50:8<1629::AID-CNCR2820500828>3.0.CO;2-1","article-title":"The growing teratoma syndrome","volume":"50","author":"Logothetis","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-5347(01)64035-7","article-title":"Teratoma with malignant transformation","volume":"159","author":"Motzer","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB57","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/01.ju.0000087822.71739.9a","article-title":"Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors","volume":"170","author":"Sheinfeld","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB58","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0022-5347(01)66053-1","article-title":"Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer","volume":"155","author":"Foster","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB59","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0022-5347(17)32754-4","article-title":"Complications of primary retroperitoneal lymph node dissection","volume":"152","author":"Baniel","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB60","first-page":"10","article-title":"Complications of retroperitoneal lymph node dissection","volume":"7","author":"Sheinfeld","year":"2002","journal-title":"AUA News"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB61","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jnci\/85.1.60","article-title":"Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy","volume":"85","author":"Bajorin","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB62","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1200\/JCO.2003.04.173","article-title":"Cardiovascular disease as a long-term complication of treatment for testicular cancer","volume":"21","author":"Huddart","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB63","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199707243370406","article-title":"Testicular germ-cell cancer","volume":"337","author":"Bosl","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB64","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1098-2388(199912)17:4<275::AID-SSU9>3.0.CO;2-U","article-title":"Late toxicity following curative treatment of testicular cancer","volume":"17","author":"Kollmannsberger","year":"1999","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000463504","article-title":"Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage I","volume":"10","author":"Fossa","year":"1984","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB66","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0094-0143(05)70035-5","article-title":"Retroperitoneal lymphadenectomy in staging and treatment. The development of nerve-sparing techniques","volume":"25","author":"Donohue","year":"1998","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB67","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0022-5347(17)42869-2","article-title":"Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation","volume":"139","author":"Jewett","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB68","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0094-0143(21)00903-4","article-title":"Nerve-sparing technique for retroperitoneal lymphadenectomy in testis cancer","volume":"17","author":"Jewett","year":"1990","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB69","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0090-4295(03)00324-8","article-title":"Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer","volume":"62","author":"Bhayani","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB70","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0090-4295(99)00411-2","article-title":"Laparoscopic retroperitoneal lymph node dissection","volume":"55","author":"Janetschek","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB71","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0090-4295(99)00289-7","article-title":"Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumors","volume":"54","author":"Nelson","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB72","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0094-0143(01)80012-4","article-title":"Laparoscopic retroperitoneal lymph node dissection","volume":"28","author":"Janetschek","year":"2001","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB73","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/01.ju.0000087796.63505.70","article-title":"Results of retroperitoneal lymph node dissection for clinical stage I and II pure embryonal carcinoma of the testis","volume":"170","author":"Pohar","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB74","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-5347(17)32830-6","article-title":"The management of patients with nonseminomatous germ cell tumors of the testis with serologic disease only after orchiectomy","volume":"152","author":"Davis","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB75","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0022-5347(01)66457-7","article-title":"The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers","volume":"155","author":"Saxman","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB76","first-page":"1184A","article-title":"Elevated serum tumor markers prior to primary RPLND predicts clinical outcome and requirements for systemic chemotherapy in patients with PN1, N2 and N3 nonseminomatous germ cell tumor","volume":"18","author":"Sheinfeld","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB77","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0022-5347(17)42067-2","article-title":"Stage II nonseminomatous germ cell tumors of the testis","volume":"140","author":"Socinski","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB78","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000463778","article-title":"Adjuvant chemotherapy in resected stage-II nonseminomatous germ cell tumors of testis. In which cases is it necessary?","volume":"10","author":"Pizzocaro","year":"1984","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB79","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0094-0143(21)00466-3","article-title":"Role of adjuvant chemotherapy in patients with stage II nonseminomatous germ-cell tumors","volume":"20","author":"Motzer","year":"1993","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB80","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0094-0143(21)00469-9","article-title":"Management of the postchemotherapy residual mass","volume":"20","author":"Sheinfeld","year":"1993","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB81","first-page":"148","article-title":"Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors","volume":"19","author":"Bajorin","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB82","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-5347(17)56173-X","article-title":"Cytoreductive surgery for metastatic testis cancer","volume":"123","author":"Donohue","year":"1980","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB83","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1200\/JCO.1992.10.4.569","article-title":"Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?","volume":"10","author":"Fossa","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB84","first-page":"65","article-title":"Integration of surgery and systemic therapy","volume":"16","author":"Donohue","year":"1998","journal-title":"Semin Urol Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB85","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1200\/JCO.1998.16.1.269","article-title":"Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer","volume":"16","author":"Steyerberg","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB86","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/(SICI)1097-0142(19981001)83:7<1409::AID-CNCR19>3.0.CO;2-8","article-title":"Postchemotherapy residual masses in germ cell tumor patients","volume":"83","author":"Stenning","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB87","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"A prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group","volume":"15","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB88","first-page":"681A","article-title":"Histology of goor risk non-seminomatous germ cell tumor patients following postchemotherapy retroperitoneal lymph node dissection after four cycles of etoposide and cisplatin","volume":"169","author":"Patel","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB89","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1200\/JCO.1993.11.7.1294","article-title":"Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections","volume":"11","author":"Fox","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB90","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0022-5347(17)32524-7","article-title":"Unusual neoplasms detected in testis cancer patients undergoing post-chemotherapy retroperitoneal lymphadenectomy","volume":"152","author":"Little","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB91","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0022-5347(01)63754-6","article-title":"Prognostic features of teratomas with malignant transformation","volume":"159","author":"Comiter","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB92","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1245\/ASO.2003.05.024","article-title":"Non-germ cell malignancy in residual or recurrent mass after chemotherapy for nonseminomatous testicular germ cell tumor","volume":"10","author":"Lutke Holzik","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB93","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1200\/JCO.2003.01.019","article-title":"Chemotherapy for teratoma with malignant transformation","volume":"21","author":"Donadio","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB94","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.1988.6.8.1248","article-title":"Late recurrence of testicular cancer","volume":"6","author":"Borge","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB95","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-4295(89)90057-5","article-title":"Late recurrence of mature teratoma in nonseminomatous testicular tumors after PVB chemotherapy and surgery","volume":"33","author":"Gelderman","year":"1989","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB96","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0022-5347(17)46031-9","article-title":"Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors","volume":"135","author":"Loehrer","year":"1986","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB97","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0022-5347(17)54013-6","article-title":"Computerized tomography","volume":"127","author":"Richie","year":"1982","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB98","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2214\/ajr.145.4.743","article-title":"Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer","volume":"145","author":"Stomper","year":"1985","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB99","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000226736","article-title":"Non-seminomatous testicular cancer clinical stage I","volume":"46","author":"Fossa","year":"1989","journal-title":"Oncology"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB100","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0022-5347(17)44439-9","article-title":"Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer","volume":"137","author":"Donohue","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB101","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1200\/JCO.1997.15.4.1455","article-title":"Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors","volume":"15","author":"Debono","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB102","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0022-5347(05)64458-8","article-title":"Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer","volume":"168","author":"Beck","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB103","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.1995.13.5.1177","article-title":"Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor","volume":"13","author":"Steyerberg","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB104","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00005392-200101000-00021","article-title":"Validation of a prediction model and its predictors for the histology of residual masses in nonseminomatous testicular cancer","volume":"165","author":"Vergouwe","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB105","first-page":"8","article-title":"Ifosfamide-based chemotherapy for patients with resistant germ cell tumors","volume":"19","author":"Motzer","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB106","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/cncr.10691","article-title":"Late recurrence in 1263 men with testicular germ cell tumors. Multivariate analysis of risk factors and implications for management","volume":"95","author":"Shahidi","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB107","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0022-5347(01)67616-X","article-title":"Complications of post-chemotherapy retroperitoneal lymph node dissection","volume":"153","author":"Baniel","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB108","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/S0022-5347(01)65476-4","article-title":"Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer","volume":"156","author":"Coogan","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB109","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1002\/1097-0142(19921101)70:9<2354::AID-CNCR2820700924>3.0.CO;2-U","article-title":"Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers","volume":"70","author":"Wood","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0090-4295(94)80269-6","article-title":"Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy","volume":"43","author":"Eastham","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB111","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1200\/JCO.1993.11.2.324","article-title":"Surgical salvage of chemorefractory germ cell tumors","volume":"11","author":"Murphy","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB112","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0094-0143(05)70037-9","article-title":"Can retroperitoneal lymphadenectomy be omitted in some patients after chemotherapy?","volume":"25","author":"Foster","year":"1998","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB113","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0090-4295(03)00579-X","article-title":"Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor","volume":"62","author":"McKiernan","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB114","first-page":"2920","article-title":"Surgery of testicular tumors","volume":"3","author":"Sheinfeld","year":"2002"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB115","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1200\/JCO.1987.5.8.1212","article-title":"Chemotherapy of metastatic seminoma","volume":"5","author":"Loehrer","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB116","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1200\/JCO.1987.5.7.1071","article-title":"The treatment of advanced metastatic seminoma","volume":"5","author":"Fossa","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB117","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-5347(01)65065-1","article-title":"Surgery for a post-chemotherapy residual mass in seminoma","volume":"157","author":"Herr","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB118","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.1996.14.2.454","article-title":"Management of residual mass in advanced seminoma","volume":"14","author":"Puc","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2004.04.029_BIB119","first-page":"1535A","article-title":"FDG-PET as prognostic indicator for seminoma residuals","volume":"22","author":"De Santis","year":"2003","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143904001036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143904001036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:51:08Z","timestamp":1761040268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143904001036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S1078143904001036"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2004.04.029","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of retroperitoneal lymph node dissection in the management of testicular cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2004.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}